From process to progress—2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis-Reference-Cited by-同舟云学术

From process to progress—2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis

Published:2019-03-25 Issue:6 Volume:179 Page:1098-1106
ISSN:1552-4825
Container-title:American Journal of Medical Genetics Part A
language:en
Short-container-title:Am J Med Genet

Author:

Ferner Rosalie E.¹,Bakker Annette²,Elgersma Ype³,Evans D. Gareth R.⁴⁵,Giovannini Marco⁶,Legius Eric⁷,Lloyd Alison⁸,Messiaen Ludwine M.⁹,Plotkin Scott¹⁰,Reilly Karlyne M.¹¹,Schindeler Aaron¹²,Smith Miriam J.⁴⁵,Ullrich Nicole J.¹³,Widemann Brigitte¹⁴,Sherman Larry S.¹⁵^ORCID

Affiliation:

1. Department of Neurology, Neurofibromatosis CentreGuy's and St. Thomas' NHS Foundation Trust, and King's College London London UK

2. Children's Tumor Foundation New York New York

3. Department of NeuroscienceErasmus Medical Center Rotterdam The Netherlands

4. Centre for Genomic MedicineSt. Mary's Hospital Manchester UK

5. Manchester Academic Health Sciences Centre (MAHSC), Division of Evolution and Genomic ScienceUniversity of Manchester Manchester UK

6. Department of Head and Neck SurgeryUniversity of California Los Angeles

7. Department of Human GeneticsUniversity Hospital Leuven Leuven Herestraat Belgium

8. Laboratory for Molecular Cell BiologyUniversity College London London UK

9. Medical Genomics Laboratory, Department of GeneticsUniversity of Alabama Birmingham Alabama

10. Department of Neurology and Cancer Center, Massachusetts General HospitalHarvard Medical School Boston Massachusetts

11. Rare Tumors Initiative, Center for Cancer ResearchNational Institutes of Health Bethesda Maryland

12. Orthopaedic Research & BiotechnologyThe Children's Hospital at Westmead Westmead New South Wales Australia

13. Department of Neurology, Boston Children's HospitalHarvard Medical School Boston Massachusetts

14. Pediatric Oncology Branch, Center for Cancer ResearchNational Cancer Institute Bethesda Maryland

15. Division of Neuroscience, Oregon National Primate Research Center, and Department of Cell, Developmental and Cancer BiologyOregon Health & Science University Portland Oregon

Funder

National Institute of Neurological Disorders and Stroke

National Institutes of Health

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajmg.a.61112

Reference32 articles.

1. The genomic landscape of schwannoma

2. Distinct structural characteristics of discoidin I subfamily receptor tyrosine kinases and complementary expression in human cancer;Alves F.;Oncogene,1995

3. Selective vulnerability of the primitive meningeal layer to prenatal Smo activation for skull base meningothelial meningioma formation

4. Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss–Driven Tumorigenesis

5. Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Congenital Anomalies;Ocular Pathology;2025

2. A rare oncological disease in a child with manifestation in the ENT organs;Meditsinskiy sovet = Medical Council;2024-05-20

3. Neurocutaneous disorders;Neurogenetics for the Practitioner;2024

4. Complex Primary Total Knee Arthroplasty in a Young Patient With Neurofibromatosis Type One and Multidirectional Knee Instability: Technical Tips and Outcome;Cureus;2023-05-30

5. Analysis of treatment sequence and outcomes in patients with relapsed malignant peripheral nerve sheath tumors;Neuro-Oncology Advances;2023-01-01